Cargando…
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Modern psychedelic research remains in an early phase, and the eventual introduction of psychedelics into clinical practice remains in doubt. In this piece, we discuss the role of blinding and expectancy in psychedelic trials, and place this in a broader historical and contemporary context of blindi...
Autores principales: | Butler, Matt, Jelen, Luke, Rucker, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481484/ https://www.ncbi.nlm.nih.gov/pubmed/36063208 http://dx.doi.org/10.1007/s00213-022-06221-6 |
Ejemplares similares
-
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
por: van den Berg, Manon, et al.
Publicado: (2022) -
So, what's it really like to work in biotech?
por: Belmont, Lisa
Publicado: (2013) -
ImmunoPET in Multiple Myeloma—What? So What? Now What?
por: Bailly, Clément, et al.
Publicado: (2020) -
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010) -
Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)